Wearable device for pain management using peripheral magnetic stimulation
Introducing a novel wearable device utilizing peripheral magnetic stimulation (PMS) for effective, non-invasive pain management. This miniaturized device offers higher magnetic field strengths than existing PEMF devices, suitable for over-the-counter use.
Overview
The University of Toronto presents a groundbreaking wearable device designed for pain management through peripheral magnetic stimulation (PMS). This innovative technology provides a non-invasive alternative to traditional neuromodulation methods, which typically rely on implantable electrodes. Our device harnesses time-varying magnetic fields to achieve significant analgesic effects, offering a powerful solution for individuals seeking relief from chronic pain. With the potential to be prescribed by physicians or used as an over-the-counter product, this wearable device is poised to transform pain management practices.
Technical specifications
Key features:
- Utilizes peripheral magnetic stimulation (PMS) with magnetic field strengths ranging from 0.1 to 0.5 Teslas.
- Miniaturized and portable design, enabling convenient use by individuals in various settings.
- Non-invasive and non-pharmacologic approach, providing a safer alternative to traditional pain management methods.
- Capable of competing with larger research devices used in Transcranial Magnetic Stimulation.
- Potential to be classified as a Class I medical device, allowing broader access through over-the-counter sales.
Technology readiness level
This device is currently at Technology Readiness Level 4, indicating that the technology has been validated in a laboratory setting. Future steps include engineering refinements to meet specific device specifications, followed by safety testing in accordance with ISO and IEC standards. Once these validations are complete, the device will be ready for commercialization.
About University of Toronto
The University of Toronto is a comprehensive public research university with three campuses in the Toronto region and a globally scaled research enterprise. Its downtown footprint is embedded within a major academic health network and an adjacent innovation district, enabling co-located labs, clinical trials, and rapid testing with end users. Companies connect through co-op and long-duration internships, sponsored research, and access to shared core facilities and prototyping resources. Research is supported by Canada’s Tri‑Agency (NSERC, CIHR, SSHRC) and the Canada Foundation for Innovation, alongside provincial programs and industry partnerships. A dedicated technology transfer office provides IP management, licensing, and startup support through a coordinated entrepreneurship network.
delivered to your inbox.